@rahat2021

   • Part II MASSIVE BLOOD TRANSFUSION OBS...  
MASSIVE BLOOD TRANSFUSION PART TWO

   • Playlist  
YouTube channel
   / @rahatq2021  
1. Activate the Massive Transfusion Protocol (MTP):
a. Identify the need for a massive blood transfusion based on the patient's clinical condition, such as severe hemorrhage or trauma.
b. Activate the hospital's MTP, which typically involves notifying the blood bank, transfusion medicine team, and other necessary healthcare providers.
2. Assess and Prepare:
a. Conduct a rapid but thorough assessment of the patient's vital signs, volume status, and laboratory values (e.g., hemoglobin, coagulation profile, blood type).
b. Ensure adequate venous access, including largebore peripheral intravenous lines or central venous access, to facilitate the rapid infusion of blood products.
3. Blood Product Selection:
a. Determine the appropriate blood products needed based on the patient's specific condition, ongoing bleeding, and laboratory results.
b. Prepare a combination of packed red blood cells (PRBCs), fresh frozen plasma (FFP), platelets, and, if necessary, cryoprecipitate.
4. Blood Compatibility and Crossmatching:
a. In the setting of massive blood transfusion, a type and screen approach is typically used to quickly determine the patient's blood type and Rh status, allowing for immediate transfusion without full crossmatching.
b. Crossmatch blood units, ensuring compatibility with the patient's blood type and Rh status. In emergent situations, group O, Rhnegative blood can be used as a universal donor.
5. Transfusion Administration:
a. Initiate the transfusion according to the established MTP guidelines.
b. Administer PRBCs, FFP, platelets, and other blood products simultaneously or in a specific ratio, as determined by the MTP or based on the patient's condition and coagulation status.
c. Use blood warmers to prevent hypothermia during rapid transfusion.
6. Continuous Monitoring:
a. Continuously monitor the patient's vital signs, including blood pressure, heart rate, oxygen saturation, and urine output.
b. Perform frequent laboratory tests, including complete blood count, coagulation profile, and blood gas analysis, to assess the patient's response to transfusion and guide further management.
7. Management of Coagulopathy:
a. In addition to blood products, consider adjunctive therapies to manage coagulopathy associated with massive blood loss, such as administration of tranexamic acid, fibrinogen concentrate, or prothrombin complex concentrates based on institutional guidelines and the patient's specific condition.
8. Fluid Resuscitation:
a. Simultaneously administer crystalloid or colloid solutions, as needed, to restore intravascular volume and maintain hemodynamic stability.
b. The ratio of blood products to crystalloid or colloid solutions may vary depending on the patient's condition, ongoing blood loss, and institutional protocols.
9. Ongoing Assessment and Reevaluation:
a. Continuously reassess the patient's response to transfusion, including vital signs, laboratory values, and evidence of ongoing bleeding.
b. Consider the need for additional imaging studies, surgical intervention, or consultation with specialists, such as a hematologist or interventional radiologist, to manage the underlying cause of bleeding.


Hi, This YouTube channel has been created to help postgraduate trainees in Obstetrics and Gynecology learn and develop clinical skills for history taking, communication, counselling, quality assurance, critical reading of the literature.